Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series.
Complement Ther Clin Pract
; 44: 101415, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1225193
ABSTRACT
BACKGROUND:
and purpose. COVID-19 is a novel viral disease causing worldwide pandemia. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to hospitalized patients with confirmed symptomatic SARS-CoV-2 infection. PATIENT PRESENTATION Thirteen patients with COVID-19 were admitted. Mean age was 73.4 ± 15.0 (SD) years. Twelve (92.3%) were speedily discharged without relevant sequelae after 14.4 ± 8.9 days. A single patient admitted in an advanced stage of septic disease died in hospital. A time-dependent improvement of relevant clinical symptoms was observed in the 12 surviving patients. Six (46.2%) were critically ill and treated in the intensive care unit (ICU). Mean stay at the ICU of the 5 surviving patients was 18.8 ± 6.8 days. In six patients (46.2%) gastrointestinal disorders accompanied COVID-19.CONCLUSION:
The observations suggest that adjunctive homeopathic treatment may be helpful to treat patients with confirmed COVID-19 even in high - risk patients especially since there is no conventional treatment of COVID-19 available at present.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Humans
/
Middle aged
Language:
English
Journal:
Complement Ther Clin Pract
Journal subject:
Nursing
/
Obstetrics
/
Perinatology
/
Complementary Therapies
Year:
2021
Document Type:
Article
Affiliation country:
J.ctcp.2021.101415
Similar
MEDLINE
...
LILACS
LIS